Full Text View
Tabular View
No Study Results Posted
Related Studies
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
This study is currently recruiting participants.
Study NCT00029107   Information provided by National Institutes of Health Clinical Center (CC)
First Received: January 5, 2002   Last Updated: August 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis C
Vasculitis
Additional conditions recognized in this trial
Hepatitis
More general conditions related to this trial
Cardiovascular Diseases
Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
RNA Virus Infections
Vascular Diseases
Virus Diseases
Interventions listed in this trial
Rituximab
More general drug interventions related to this trial
Antineoplastic Agents
Antirheumatic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services